Trending:
News
-
14 December 2018
Russia and Rusal complete Ebola vaccinations in Guinea
The Ministry of Health of the Russian Federation and domestic aluminium producer Rusal have completed the vaccination against Ebola virus in the Republic of Guinea.
-
14 December 2018
Deals this week: Vect-Horus, Amgen, Bristol-Myers Squibb
Vect-Horus has signed a research agreement with Janssen Pharmaceuticals for the development of neurodegenerative disease treatments.
-
14 December 2018
Mylan announces victory over Sanofi in Lantus patent claims
Generic drug maker Mylan has announced that the US Patent and Trademark Appeal Board (PTAB) invalidated Sanofi’s patent infringement claims over insulin drug Lantus.
-
14 December 2018
Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals
Canada-based Bausch Health Companies (previously Valeant Pharmaceuticals) has entered a definitive agreement to acquire select assets of Synergy Pharmaceuticals for around $200m and certain assumed liabilities.
-
13 December 2018
Janssen’s Tremfya shows superiority in plaque psoriasis to Novartis’ drug at 48 weeks
Johnson & Johnson subsidiary Janssen has announced results from its phase III Eclipse trial comparing its Tremfya (guselkumab) with Novartis’ Cosentyx (secukinumab) in adults with moderate to severe plaque psoriasis.
-
13 December 2018
Lilly teams up with AC Immune for Alzheimer’s drug
Eli Lilly has signed a licence and collaboration agreement with Swiss biotech AC Immune for the research and development of tau aggregation inhibitor small molecules to treat neurodegenerative disorders, including...
-
13 December 2018
EC approves self-administration of Novartis’ Xolair
The European Commission (EC) has approved the prefilled syringe (PFS) of Novartis’ Xolair (omalizumab) medication for self-administration by patients with severe allergic asthma (SAA) and chronic spontaneous urticaria (CSU).
-
13 December 2018
NIH to support HIV care and prevention research in the US
The National Institute of Allergy and Infectious Diseases (NIAID), a National Institutes of Health (NIH) division, has announced plans to fund HIV care and prevention research in the southern US.
-
12 December 2018
GARDP, Eisai and Takeda join forces to identify new antibiotics
The Global Antibiotic Research and Development Partnership (GARDP) in Switzerland has partnered with Eisai and Takeda Pharmaceutical in a bid to discover new antibiotics.
-
12 December 2018
Vect-Horus and Janssen partner for neurodegenerative disease treatment
Vect-Horus has entered a research collaboration agreement with Johnson & Johnson subsidiary Janssen Pharmaceuticals for treating neurodegenerative diseases.